Get Free Essays

MARKETING AND PRICING PROBLEMS.   Term Paper ID:30043 Click to get this paper

Essay Subject: Analyzes pricing as a major priority of the marketing mix.... More...

12 Pages / 2700 Words 13 sources, 15 Citations, MLA Format $48.00 Return to List of Papers

Paper Abstract: Analyzes pricing as a major priority of the marketing mix. End price of the product. Issue of consumer affordability & company profits. Pricing policies of the pharmaceutical industry. AIDS medication high pricing. Drug company lobbying. Fair pricing concept. Altenative pricing strategies such as tier pricing. Role of government regarding subsidies, provision of drugs & medication to the elderly. Paper Introduction: PRICING IN THE MARKETING MIX Executive Summary Production, distribution, and marketing all add up to the desire for consumer acceptance of a product or service. But, within that marketing mix pricing is a major priority. The reason is simple: the product has to be worth the end price. Pricing is a component of the marketing mix and thereby is not treated in isolation from the broad objectives…developed…which might include high return on investment or high market share (Paley 273). The customer has to be able to afford to buy at various price points. The pricing has to be established so the company can earn a fair return on its investment in facilities, raw material, marketing expenses and other overhead. There are a Text of the Paper: The entire text of the paper is shown below. However, the text is somewhat scrambled. We want to give you as much information as we possibly can about our papers and essays, but we cannot give them away for free. In the text below you will find that while disordered, many of the phrases are essentially intact. From this text you will be able to get a solid sense of the writing style, the concepts addressed, and the sources used in the research paper. The reason is simple the product has return on investment or high market share Paley return on itsinvestment in facilities raw material industry whose pricing policies for better or worse-are suggest the pluses andminuses of alternative crisis especially in Africa Pharmaceutical companies such as Merckand Abbott cannot afford the high drugprices one of the only hopes for the The major problem is not merely the spread who blame the company for not providingits throughout theworld The death rate from of the cost Finally after some pressure of the worlds HIV-positive people was a PR ploy and that pricecuts In terms of total dosage Africa is not significant because will see pricing has become too big an issue strategy objectives broad policy strategy implementation andadjustments a proportion of customers are price-sensitive thefirm Evans as one of the best institutional images fallon its remedial The majority of consumer complaintsabout the pharmaceutical less As a result H to buy prescription drugs at techniques and frontalassaults to stop any sort of U S spending on drugs is done by those News Merrill Lynch's research points out that even suggest raising prices andaccepting market share at the same time Dolan While this seems to be too high you have little alternative This falls under the close to zero for a life-saving and are at the mercy of the drug companies' public wrongly thatgeneric drugs do not in sales of that particularproduct will lessen Looking at with sales force and distributionmanagement that could go awry what are known as detail men who receive a generous orderto maintain the same income the a difficultcultural problem with its sales force This from thepharmaceutical company why the same drugs cost would be some alternative pricing strategies They have guru wrote in his landmark book Innovations pharmaceutical industryto be somehow different because unlike toothpaste or soap an alternative But here is by the elderly and therefore no howto reach the website and asked to submit a special advantages for certain medications depending on the agegroup for legislation is now aimed would be purchased fromthe drug companies along thedistribution channel but the actual manufacturing in the long run the consumer would case of thepharmaceutical companies It is market share When competition does appear for of bottom lineprofitability however Taylor gives an cut the catalog price by third less revenue Taylor The consumer benefits of course The a profit and to add profits there is the feeling of price gouging That is obvious however that the AIDS No pricing policy is ever chiseled in to make a decision on whether theobjective should be shareholder need and corporate responsibility with consumer lifeenhancement On the securityanalysts and shareholders about the continuing profitability adjusted the governmentmay step in with price legislation In their to the price of the products that there is little if any pricecompetition Conclusion or marketing a similar drug So the real age will be difficultones for the will hound the pharmaceutical company J and Simon Herman Power Pricing New York The in Marketing New York McGraw-Hill co za corporate main aspPaley for Seniors Act' H R Citizen web site Merrill Lynch Finds desire forconsumer acceptance of a product or in isolation from the broad has to be established so wherepricing has become a dominant perhaps overly dominant overview that will analyze the current pricingproblems affects the marketing mix and public perception of the company prices or literally offer the drugs along with its rival Abbott Labs to provide Merck and itscompetitors Do whatever is necessary at cost if medicines and drugs Secondly Merck needs to countries It is the most widely used and cost-effective Crixivan But the medication is expensive and Africans at cost The industry has come under pressure forward to fund AIDS treatment Gellene C but also offered them to other emergingnations What is varying from country to country This manufacturers Pricing should neverhave become the overriding issue For example prices changed too frequently pricing policy problem within thepharmaceutical industry's marketing course pricing has now caused Congress to bus to Canada to buy prescriptions The Prescription Drug Fairness for the bill no auth The will be pro-business But Any plan affecting seniors is highly the industry continues to introduce innovative expensive medicines to the Seniors Act in force would be Citizen There industry You can increase market share oryou can increase you can buy a Honda be investigated in each specific to switch Dolan And there you have the somehow There are generic drugs of course but the the patents expire on branded assumption Bonama The author also lists pricing structure as the dollar volume theyproduce a sort of institute a percent cut in itsdrug pricing for its price evenfurther then Merck a pricing policy that might beconsidered fair arcane argument atbest when the consumers The fact is that companies are in businessto For any other industry thisis certainly very a hurdle consumers have to pass TheyNEED the product whatever regular customers This would be limited sources eliminating the middle man i e thepharmacist with his available in librariesand most senior centers Tier intended for senior citizens this to the consumers For example which these drugs would be resold to the consumers withprescriptions to achieve No one disputes the of course have years of patentprotection and olderproduct ends up with a reduced price Price is demonstrably effective for arthritis sufferers The basic patents everything is as it was before the easy tolook at the pricing strategies and run into the billions of dollars a Public Relations war which does the companiesabsolutely no their governments to pay From astrictly humanitarian point of view to have dissimilar objectives and therefore different pricing strategies means of apricing policy in the pharmaceutical industry would negativeside this may well impact the bottom duplication of distribution efforts to and lengthen lifeexpectancy and reduce disease Nevertheless there are not dozens of are necessary They MUST be purchased The only competition frustration that is reaching the halls of Congress The next basis than almost any other between shareholders and consumers WORKS CITEDBonoma Thomas V The Marketing Companies Reduce Prices on AIDS Drugs Test in Africa Los mg co za mg news Competitive Marketing Strategies Radnor PA Chilton Book Company No U S News and World by only www citizen org congress PRICING IN THE MARKETING MIX Executive Summary Production distribution and to beworth the end price Pricing is a component of The customer has to be able to marketing expenses and otheroverhead There coming under scrutiny not merely by consumer advocates but bygovernmental pricing methods Statement of Marketing pricing problem There Labs which produce the new drugs to combat the disease Merck one of the pharmaceutical companies that is producing alarming AIDS epidemic throughoutAfrica There of the disease but the inability medicines free or at cost HIV-related infections dropped from to primarily due to the highly the announcement was made on March that Merck live In announcing the price cuts the company said were long overdue Merck unlike some of its competitors people can'tafford it Gellene C Abbott one in the overallpharmaceutical marketing mix It has skewed the Evans However there are some indications that thepricing policy has major problems conforming with pricing legislation Evans Given these sword when it comes to consumer pricing policies come from American seniorcitizens For one thing they R S a jointHouse-Senate bill up to off current retail prices As of May House pricing legislation The industry feels thatwith Bush over the age of Yet only Merck for example based on sales figures listed loss Dolan This seems based on a sensible the pharmaceutical company maybe far different from ordinary industries headingof price elasticity The degree of drug to near infinite values for common commodities pricing policies whichgenerally relate to the have the same quality as some alternatives There are almost no examples and cause severe problems Assume therefore that the salary plusallowances for product placement in doctors' salesmen would have to increase theirsales volume And if a is to indicate that there is more at stake than less in Canada and Mexico even in Europe than to answerthe proverbial question To whom do we the in Marketing The primary business of anybusiness is powders TVsets or shampoos medicines mean life-or-death ONE alternative Tier Pricing Provide certain consumer can cry agediscrimination There would also be an opportunity password If seniors do nothave their own which these drugs are intended Government Distribution Through the Department at a COST-PLUS basis HEW would then make cost is HEW wouldbuy the drugs in quantity at say benefit tremendously and the drug companies would not be losing only their pricing policies which is oftencondemned and example Lipitor is now taking example Roughly to percent of Upjohn's earnings to to build share Its major competitor immediately company does not Pluses and minuses If this were all along the distributionline but that it needs the the companies knowwe need the drugs and epidemic in parts of Africa DOES stone In fact it is possiblefor sales or profit-based Of course companies are not inbusiness plus side pricing might as suggested in the alternativesabove of thecompany On the one hand companies may favor companies use billions of dollars to develop new innovative Granted there is not much competition in some Unlike most consumer products the pharmaceutical industry is key topricing may well be consumer anger and struggle between the needy consumer and the wealthypharmaceutical companies Pricing for manyyears to come unless some price accommodations Free Press Evans Joel R and Berman Barry Marketing Book Co Karon Tony When Norton How to Develop a Strategic Marketing Plan S www citizen org congress drugs the Prescription Drug Fairness to Seniors service But within that marketing mixpricing is a major priority objectives developed which might include high the company can earn a fair issue Among them isthe pharmaceutical and provide some alternatives as well as setting the price than the currentAIDS atcost to people and entire nations that AIDS relief for the poor nations in Africa It isconsidered needed to help stem theAIDS epidemic find a means of dialogue or opencommunication with AIDS activists protease inhibitor for the treatment of HIV-AIDS are unable toafford it even if the governments subsidize some to lower the cost of AIDS drugs in Africa where AIDS activists complained that this price cut somewhat alarming is a financial analyst's statement that is thepolicy that Merck also needs to follow As we There are five stages in developing apricing is difficult to explain toconsumers to high mix It is especially disconcerting tosee Merck rated attempt to take someaction even if it seems Canadian pricing for theselfsame drugs is as much as Seniors Act' would allow million Medicare beneficiaries Drug industry is spending millions in lobbying important to the drug industry About forty percent of all treat diseases that afflict seniors U S are those pricing experts who the profit but it's tough to do both But if you need a specific drug and it ispriced case Price elasticities may range from dilemma for many who depend on life-saving drugs pharmaceutical industryis doing everything possible to try to convince the drugs the company'sstock tends to go down knowing that income one of the key factors along salary-plus-commission which is not rare except in thecases of those drugs which are applicable to seniors In either has to respond and perhaps face And yet there is still no viable reply companies use quality control and efficacy as excuses What make a profit As Theodore Levitt the marketing logical But people perceive the the price There seldom is to those drugs that are mainlyused mark-up Seniors could be given instructions about pricing could also be established through themail with is the group complaining the mostand for whom government if a month'ssupply of drugs now retails for including profits where necessary Yes it would increase the governmentbureaucracy but quality of the products in the there are seldom competitors to take away cutting is seldom the answer in terms on it were set to expire so Upjohn price cuts Except that every sale generates a respond that the corporation deservesnot merely to make From the consumers' side ofcourse good and does not solve the pricing problems It is any other pricing policy must fall bythe wayside here Evans In the case of thepharmaceutical companies the key is be to balance publicneed with line and create concern by holddown costs On the other hand unless prices are those costs need to berecouped adding serious dollar amounts brands tochoose from Then again this means is among very few drugcompanies developing few years as America continues to industry More than anyother strategy pricing Edge New York The Free Press Dolan Robert Angeles TIMES March Levitt Theodore Innovations march mar-illiteracy htmlMerck website www merck author listed Summary of Prescription Drug Fairness Report Feb No author listed Public merrill htm marketing all add up to the the marketing mix and thereby is not treated afford to buy at various price points Thepricing are a number of industries in the headlines lately agencies world-wide There will be an is no better example of how pricing are underextreme pressure to either lower AIDSmedications has been under extreme pressure is really only one marketing strategy for of its victims to pay for expensive Merck produces Crixivan which is nowavailable in more than effective new protease inhibitors suchas Co said it would sell two AIDS drugs there it hopes governments and international agencies will step did not stopwith price cuts in South Africa of Merck's competitors said that itwould price its AIDS drugs entire marketing program and has put legislative pressure on the is inadequate not working or simply wrong parameters there is a pricing confidence in its drug pricingstrategies Of cannot understand why when they take achartered is attempting to target unfair pricing members and Senators have co-sponsored in the White House the pressure two-thirds of seniors have help with those costs even as in its annual report Actual sales would be with fairlycommon perception in almost any If you feel a Ford is pricedtoo high price elasticity is an empirical question that has to where a slight price difference can induce the customer expense of research and development costs thathave to be recouped their branded ones Yet timeand time again when where price implementation isn't done bysheer sales force is compensated on offices and hospitals Suppose Merck as an example were to competitor say Abbott Labs lowers merely public orcompetitive pressures when it comes to they do in the U S It is an industry owe allegiance theshareholders or the to stay in business Levitt cure-and-relief and abetter quality of life Pricing is drugs to seniors showing ID at a lower price thanfor to develop thisstrategy through internet computers there are always computers of Health Education and Welfare specificdrugs the drugsavailable at no additional cost plus percent or That isthe price at money making up in publicrelations what they might otherwise fail is at risk New drugs marketshare from the older Zocor in hypertension medications usually the came from the prescription drug Motrin Motrin matched the price cuts and strictly an industry-oriented report it would be money to increase its research and developmentcosts which they are holding us ransom It can become deserve a greaterrespect for the inability of the people or different firms in the same industry for altruism Nevertheless perhaps the most effective be adjusted for certain segments of the population On the want to adjust their percent ofprofitability and examine any efficacious drugs that enhance life style of the specifics of thedrug business i e unlike toothpaste notbothered by discretionary spending for their products They frustration about pricing an angerand strategies must be upgraded and adjustedon a far more frequent are made There willcontinue to be a tug of war New York MacMillan Publishing Company Gellene Denise the President is a Dissident TIME Magazine July www Boca Raton FL St Lucie Press Taylor James W factshts drugp ricing prescriptionsummar y htmNo author listed Drug Dilemma Act Would Cut Drug Company Revenues The reason is simple the product has return on investment or high market share Paley return on itsinvestment in facilities raw material industry whose pricing policies for better or worse-are suggest the pluses andminuses of alternative crisis especially in Africa Pharmaceutical companies such as Merckand Abbott cannot afford the high drugprices one of the only hopes for the The major problem is not merely the spread who blame the company for not providingits throughout theworld The death rate from of the cost Finally after some pressure of the worlds HIV-positive people was a PR ploy and that pricecuts In terms of total dosage Africa is not significant because will see pricing has become too big an issue strategy objectives broad policy strategy implementation andadjustments a proportion of customers are price-sensitive thefirm Evans as one of the best institutional images fallon its remedial The majority of consumer complaintsabout the pharmaceutical less As a result H to buy prescription drugs at techniques and frontalassaults to stop any sort of U S spending on drugs is done by those News Merrill Lynch's research points out that even suggest raising prices andaccepting market share at the same time Dolan While this seems to be too high you have little alternative This falls under the close to zero for a life-saving and are at the mercy of the drug companies' public wrongly thatgeneric drugs do not in sales of that particularproduct will lessen Looking at with sales force and distributionmanagement that could go awry what are known as detail men who receive a generous orderto maintain the same income the a difficultcultural problem with its sales force This from thepharmaceutical company why the same drugs cost would be some alternative pricing strategies They have guru wrote in his landmark book Innovations pharmaceutical industryto be somehow different because unlike toothpaste or soap an alternative But here is by the elderly and therefore no howto reach the website and asked to submit a special advantages for certain medications depending on the agegroup for legislation is now aimed would be purchased fromthe drug companies along thedistribution channel but the actual manufacturing in the long run the consumer would case of thepharmaceutical companies It is market share When competition does appear for of bottom lineprofitability however Taylor gives an cut the catalog price by third less revenue Taylor The consumer benefits of course The a profit and to add profits there is the feeling of price gouging That is obvious however that the AIDS No pricing policy is ever chiseled in to make a decision on whether theobjective should be shareholder need and corporate responsibility with consumer lifeenhancement On the securityanalysts and shareholders about the continuing profitability adjusted the governmentmay step in with price legislation In their to the price of the products that there is little if any pricecompetition Conclusion or marketing a similar drug So the real age will be difficultones for the will hound the pharmaceutical company J and Simon Herman Power Pricing New York The in Marketing New York McGraw-Hill co za corporate main aspPaley for Seniors Act' H R Citizen web site Merrill Lynch Finds desire forconsumer acceptance of a product or in isolation from the broad has to be established so wherepricing has become a dominant perhaps overly dominant overview that will analyze the current pricingproblems affects the marketing mix and public perception of the company prices or literally offer the drugs along with its rival Abbott Labs to provide Merck and itscompetitors Do whatever is necessary at cost if medicines and drugs Secondly Merck needs to countries It is the most widely used and cost-effective Crixivan But the medication is expensive and Africans at cost The industry has come under pressure forward to fund AIDS treatment Gellene C but also offered them to other emergingnations What is varying from country to country This manufacturers Pricing should neverhave become the overriding issue For example prices changed too frequently pricing policy problem within thepharmaceutical industry's marketing course pricing has now caused Congress to bus to Canada to buy prescriptions The Prescription Drug Fairness for the bill no auth The will be pro-business But Any plan affecting seniors is highly the industry continues to introduce innovative expensive medicines to the Seniors Act in force would be Citizen There industry You can increase market share oryou can increase you can buy a Honda be investigated in each specific to switch Dolan And there you have the somehow There are generic drugs of course but the the patents expire on branded assumption Bonama The author also lists pricing structure as the dollar volume theyproduce a sort of institute a percent cut in itsdrug pricing for its price evenfurther then Merck a pricing policy that might beconsidered fair arcane argument atbest when the consumers The fact is that companies are in businessto For any other industry thisis certainly very a hurdle consumers have to pass TheyNEED the product whatever regular customers This would be limited sources eliminating the middle man i e thepharmacist with his available in librariesand most senior centers Tier intended for senior citizens this to the consumers For example which these drugs would be resold to the consumers withprescriptions to achieve No one disputes the of course have years of patentprotection and olderproduct ends up with a reduced price Price is demonstrably effective for arthritis sufferers The basic patents everything is as it was before the easy tolook at the pricing strategies and run into the billions of dollars a Public Relations war which does the companiesabsolutely no their governments to pay From astrictly humanitarian point of view to have dissimilar objectives and therefore different pricing strategies means of apricing policy in the pharmaceutical industry would negativeside this may well impact the bottom duplication of distribution efforts to and lengthen lifeexpectancy and reduce disease Nevertheless there are not dozens of are necessary They MUST be purchased The only competition frustration that is reaching the halls of Congress The next basis than almost any other between shareholders and consumers WORKS CITEDBonoma Thomas V The Marketing Companies Reduce Prices on AIDS Drugs Test in Africa Los mg co za mg news Competitive Marketing Strategies Radnor PA Chilton Book Company No U S News and World by only www citizen org congress If this paper is not what you are looking for, you can search again: Search for: or Click here to request an essay written just for you.